ZYME Q1 2019 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+29712.5% YoY

Gross Profit

-$6M-46.5% margin

Operating Income

-$15M-122.0% margin

Net Income

-$14M-114.4% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

-58.8%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$238M

Total Liabilities

$68M

Stockholders' Equity

$170M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$40,000	+29712.5%
Gross Profit	-$6M	-$13M	+57.5%
Operating Income	-$15M	-$20M	+27.6%
Net Income	-$14M	-$21M	+35.7%

Revenue Segments

Performance Milestone

$8M95%

License and Service

$395,0005%